Location History:
- Suzhou, CN (2013 - 2021)
- Jiangsu, CN (2017 - 2021)
Company Filing History:
12 out of 12 
1 out of 1 
1 out of 1 Years Active: 2013-2025
Title: The Innovative Mind of Jiandong Yuan
Introduction
Jiandong Yuan is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of medicine. With a remarkable portfolio of 13 patents, Yuan has made valuable advancements in pharmaceutical compositions, particularly in the treatment of diabetes and obesity. His work showcases the intersection of scientific innovation and therapeutic application.
Latest Patents
Among his latest patents are the GIP and GLP-1 dual receptor agonist, which highlights a novel pharmaceutical composition designed to enhance the effectiveness of treatment for conditions such as diabetes and obesity. This invention specifically relates to a compound represented by formula I, demonstrating excellent agonist activity and pharmaceutical efficacy in regulating blood sugar levels and controlling body weight. The application of this compound has promising prospects for clinical use in managing diabetes and its complications, thereby positively impacting public health.
Additionally, another notable patent involves a preparation method for an ecteinascidin compound and its intermediate. This method introduces a new compound, QT9, and presents an efficient approach for synthesizing ecteinascidin compounds with high selectivity and yielding results that overcome previous challenges in the field. The improved preparation method is particularly influential for industrial applications.
Career Highlights
Jiandong Yuan's career is marked by his association with reputable entities such as Brightgene Biomedical Technology Co., Ltd. and Brightgene Biomedical Technology (Suzhou) Co., Ltd. Throughout his career, he has played a pivotal role in driving innovative research and development, positioning himself as a key player in the pharmaceutical industry.
Collaborations
Yuan has collaborated with esteemed colleagues, including Yangqing Huang and Zhanli Sun, to further his research initiatives. These collaborations have contributed to enhancing the quality and scope of his inventions, leveraging shared expertise to foster innovation.
Conclusion
Jiandong Yuan exemplifies the spirit of innovation within the pharmaceutical sector, with a focus on addressing significant health challenges. His continued work in developing novel therapeutic compounds not only showcases his ingenuity as an inventor but also reinforces the importance of collaboration and effective research in advancing medical science. As he continues to build on his foundational work, the contributions of Jiandong Yuan are poised to make a lasting impact on healthcare.